Critics say Gov. Mike Braun’s steps to get a handle on Indiana’s ballooning Medicaid budget limits information for potential ...
AIM ImmunoTech (AIM) announced that the final Clinical Study Results for the “Study to Evaluate the Efficacy and Safety of Ampligen in Patients ...
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to ...